今天是:2020-08-05 星期三

Laparoscopic subtotal cholecystectomy for Mirizzi syndrome: A report of case series
下载XML文档

注册号:

Registration number:

ChiCTR1800019590 

最近更新日期:

Date of Last Refreshed on:

2018-11-19 

注册时间:

Date of Registration:

2018-11-19 

注册号状态:

预注册  

Registration Status:

Prospective registration  

注册题目:

Laparoscopic subtotal cholecystectomy for Mirizzi syndrome: A report of case series 

Public title:

Laparoscopic subtotal cholecystectomy for Mirizzi syndrome: A report of case series 

注册题目简写:

 

English Acronym:

 

研究课题的正式科学名称:

Laparoscopic subtotal cholecystectomy for Mirizzi syndrome: A report of case series 

Scientific title:

Laparoscopic subtotal cholecystectomy for Mirizzi syndrome: A report of case series 

研究课题代号(代码):

Study subject ID:

 

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

 

申请注册联系人:

Jiro Kimura 

研究负责人:

Jiro Kimura 

Applicant:

Jiro Kimura 

Study leader:

Jiro Kimura 

申请注册联系人电话:

Applicant telephone:

+47 351-3101 

研究负责人电话:

Study leader's telephone:

+47 351-3101 

申请注册联系人传真 :

Applicant Fax:

 

研究负责人传真:

Study leader's fax:

 

申请注册联系人电子邮件:

Applicant E-mail:

diamond0519@hotmail.co.jp 

研究负责人电子邮件:

Study leader's E-mail:

diamond0519@hotmail.co.jp 

申请单位网址(自愿提供):

Applicant website(voluntary supply):

 

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

 

申请注册联系人通讯地址:

3-4-32, Todaijima, Urayasu, Chiba, Japan 

研究负责人通讯地址:

3-4-32, Todaijima, Urayasu, Chiba, Japan 

Applicant address:

3-4-32, Todaijima, Urayasu, Chiba, Japan 

Study leader's address:

3-4-32, Todaijima, Urayasu, Chiba, Japan 

申请注册联系人邮政编码:

Applicant postcode:

 

研究负责人邮政编码:

Study leader's postcode:

 

申请人所在单位:

日本国东京湾浦安川医疗中心 

Applicant's institution:

Tokyo Bay Urayasu Ichikawa Medical Center 

是否获伦理委员会批准:

否 

Approved by ethic committee:

NO 

伦理委员会批件文号:

Approved No. of ethic committee:

 

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

 

Name of the ethic committee:

 

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 

伦理委员会联系人:

 

Contact Name of the ethic committee:

 

伦理委员会联系地址:

 

Contact Address of the ethic committee:

 

伦理委员会联系人电话:

Contact phone of the ethic committee:

 

伦理委员会联系人邮箱:

Contact email of the ethic committee:

 

研究实施负责(组长)单位:

日本国东京湾浦安川医疗中心 

Primary sponsor:

Tokyo Bay Urayasu Ichikawa Medical Center 

研究实施负责(组长)单位地址:

日本国千叶县浦安Todaijima3-4-32 

Primary sponsor's address:

3-4-32, Todaijima, Urayasu, Chiba, Japan 

试验主办单位(项目批准或申办者):

Secondary sponsor:

经费或物资来源:

无 

Source(s) of funding:

none 

研究疾病:

米里齐综合征 

Target disease:

Mirizzi syndrome 

研究疾病代码:

 

Target disease code:

 

研究类型:

观察性研究 

Study type:

Observational study 

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study 

研究目的:

We investigated the usefulness of laparoscopic subtotal cholecystectomy for Mirizzi syndrome from charts in our institution. 

Objectives of Study:

We investigated the usefulness of laparoscopic subtotal cholecystectomy for Mirizzi syndrome from charts in our institution.  

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

研究设计:

单臂 

Study design:

Single arm 

纳入标准:

Patients who underwent laparoscopic subtotal cholecystectomy for Mirizzi syndrome. 

Inclusion criteria

Patients who underwent laparoscopic subtotal cholecystectomy for Mirizzi syndrome. 

排除标准:

none. 

Exclusion criteria:

none. 

研究实施时间:

Study execute time:

From2018-11-18To 2018-11-18 

征募观察对象时间:

Recruiting time:

From2018-11-18To 2018-11-18 

干预措施:

Interventions:

组别:

Cases

样本量:

2

Group:

Cases

Sample size:

干预措施:

Nil

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

日本 

省(直辖市):

千叶 

市(区县):

 

Country:

Japan 

Province:

Chiba 

City:

 

单位(医院):

浦安Ichikawa医疗中心 

单位级别:

 

Institution
hospital:

Tokyo Bay Urayasu Ichikawa Medical Center  

Level of the institution:

 

测量指标:

Outcomes:

指标中文名:

complication rate

指标类型:

主要指标 

Outcome:

complication rate

Type:

Primary indicator 

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它 

说明

Fate of sample:

Others 

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 53 years
最大 Max age 61 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

N/A

Randomization Procedure (please state who generates the random number sequence and by what method):

no randomization

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

原始数据公开时间:

The time of sharing IPD:

即时公开/Real time access

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Not stated

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

charts in our institution

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Not stated

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

From charts.

数据管理委员会:

Data Managemen Committee:

有/Yes

注册人:

Name of Registration:

 2018-11-19
返回列表